XASX
BP8
Market cap2mUSD
Oct 21, Last price
0.02AUD
Name
Stemcell United Ltd
Chart & performance
P/E
—
P/S
—
EPS
—
Vol. 1Y
537.03%
Shs. 5Y
1.38%
Rev. 5Y
-16.52%
Div Yld LY
—
Div Yld TTM
—
Revenues
3m
+877.51%
Net income
-2m
L+20.27%
CFO
-2m
L+129.67%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
BPH Global Ltd, along with its associated entities, specializes in the procurement, production, promotion, and sale of traditional medicinal items. Its operational reach spans Australia, Singapore, China, and the broader Southeast Asian market. The company's diverse product range features both unprocessed and refined bird's nest offerings, alongside marine botanicals like Caulerpa Lentillifera (sea grapes) and various seaweeds. These products are utilized across multiple industries, including food, nutrition, healthcare, dietary supplements, cosmetics, and personal care. Headquartered in Melbourne, Australia, the company was founded in 1984 and transitioned to its current name, BPH Global Ltd, in June 2023, having previously been known as Stemcell United Limited.
Key people
Paul Stephenson
Non-Executive Independent Chairman of the Board · since 2023
Chow-Yee Koh
Chief Financial Officer · since 2023
Part Time Executive Director · since 2023
Deepak Jha
Executive Director · since 2025
Matthew Leonard
Managing Director, Executive Director · since 2023
Company Secretary · since 2024
Michael Huang
Non-Executive Director · since 2023
Legal address
COMPANY MATTERS PTY LIMITED
LEVEL 12
680 GEORGE STREET
SYDNEY, NSW 2000
AU
LEVEL 12
680 GEORGE STREET
SYDNEY, NSW 2000
AU
Headquarters
43 GURRS ROAD
BEULAH PARK, SA 5067
AU
BEULAH PARK, SA 5067
AU
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT |